Agepha Pharma

Home
Agepha Pharma

We supply classic, safe, and affordable drugs that have been trusted by thousands of happy customers since 1947. We care about building trust through honesty.

We care about improving quality of our customers' lives. We're here to help, because we care.

21/10/2025

Last week, AGEPHA Pharma attended The Pharmacy Show in , where we had the pleasure of meeting and healthcare professionals from across the United Kingdom.

We showcased our product range, introduced exciting new additions, and exchanged valuable insights on advancing patient care.

Thank you to everyone who stopped by to connect with us!

12/10/2025

AGEPHA Pharma is at The Pharmacy Show at NEC Birmingham from October 12–13!

Come say hello at Booth A80 and discover our eye care range designed to support healthier, more comfortable vision.

We look forward to meeting you there!

17/09/2025

The AGEPHA Pharma team was pleased to attend the at the Bella Center in Copenhagen.

We had the opportunity to showcase our ophthalmic portfolio and connect with clinicians from Europe, discussing the evolving needs in eye care and our treatment options.

Thank you to everyone who visited our booth, we look forward to meeting you again next year!

12/09/2025

AGEPHA Pharma will be attending at the Bella Center in from September 12–16.

You can find us in Hall C, Booth C.1059, where we will be showcasing our ophthalmic range.

We look forward to engaging with healthcare professionals at this leading ophthalmology congress.

31/07/2025

Heading to ?

Join in Boston|MA|August 1–3.

Stop by our booth to learn how LODOCO® (colchicine 0.5 mg) is helping reduce cardiovascular risk in patients—by targeting residual CV .

For more information 🔗 lodoco.com

We look forward to seeing you there!

04/07/2025

More Than Lipids – It’s Time to Treat CVD Inflammation

The EKSTROM trial confirms it: Colchicine 0.5 mg daily slows coronary plaque progression in patients with stable CAD.

Prescribing colchicine 0.5 mg:
➡️ Targets residual
➡️ Supports plaque stabilization
➡️ Works synergistically with statin therapy
➡️ Easy once-daily regimen

Learn more: https://bit.ly/4kmU7Kq

01/07/2025

Low-Dose Colchicine is no longer only approved for gout. It’s now changing the landscape of care.

26/06/2025

update
Daily colchicine 0.5 mg slowed artery hardening (calcified plaque) and showed early shrinkage of soft, rupture-prone plaque in stable .

Read more: Learn more: https://bit.ly/4kmU7Kq

18/06/2025

This month marks the 20-year anniversary of and MACUSAN Plus!!

We’re proud of the positive impact the MACUSAN Range has had over the past two decades and look forward to continuing to help patients protect their vision for years to come.

28/05/2025

The AGEPHA Pharma team was pleased to attend The Royal College of Ophthalmologists Annual Congress 2025 at the ACC Liverpool.

We had the opportunity to present our ophthalmic portfolio and engage in valuable discussions with clinicians from across the UK about current needs in eye care and our range of treatment options.

Thank you to all who visited our booth, we look forward to seeing you next year!

19/05/2025

AGEPHA Pharma is excited to be part of RCOphth 2025 in Liverpool!

We're showcasing our full range of trusted ophthalmic treatments, from prescription therapies to supportive care.

Come visit us at Booth 52 to connect with our team and discover how we're supporting eye health across the UK.

02/05/2025

Ocusan Eye Drops offer gentle, preservative-free relief for in easy-to-use single-dose vials, each containing soothing sodium hyaluronate. Their portable design fits effortlessly into your routine. Perfect for hydration anytime, anywhere.

Address

Website

http://www.agephapharma.com/

Alerts

Be the first to know and let us send you an email when Agepha Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City: